Downregulation of TGF-beta 1 gene expression in anterior pituitary cells treated with forskolin

Cytokine. 1997 Feb;9(2):106-11. doi: 10.1006/cyto.1996.0143.

Abstract

Transforming growth factor beta 1 (TGF-beta 1) has recently been shown to inhibit the growth of lactotropes by an autocrine/paracrine mechanism. Because the growth and function of lactotropic cells in the anterior pituitary are under control by hormones that modulate intracellular cAMP levels, the effect of a cAMP elevating agent forskolin on TGF-beta 1 and TGF-beta 1 gene expression in primary cultures of anterior pituitary cells was tested. Treatment with a dose of forskolin (5 microM), known to induce PRL gene transcription, significantly inhibited TGF-beta 1 levels in culture medium and TGF-beta 1 mRNA levels in cellular extracts. Nuclear run-off transcription analysis revealed that the forskolin effect on TGF-beta 1 mRNA expression is due to reduced transcription initiation rates. These data suggest that the transcription of TGF-beta 1 may be regulated by cAMP dependent mechanisms in anterior pituitary cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cells, Cultured
  • Colforsin / pharmacology*
  • Down-Regulation* / drug effects
  • Female
  • Pituitary Gland, Anterior / cytology
  • Pituitary Gland, Anterior / drug effects
  • Pituitary Gland, Anterior / metabolism*
  • RNA, Messenger
  • Rats
  • Rats, Sprague-Dawley
  • Transcription, Genetic / drug effects
  • Transforming Growth Factor beta / genetics*
  • Transforming Growth Factor beta / metabolism

Substances

  • RNA, Messenger
  • Transforming Growth Factor beta
  • Colforsin